TMRW Life Sciences

company

About

TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.

Details

Last Funding Type
Funding Round
Industries
Biotechnology,Health Care,Life Science,Software
Founded date
Jan 1, 2018
Number Of Employee
101 - 250
Operating Status
Active
Legal Name
TMRW Life Sciences, Inc.

TMRW is a life sciences technology company setting new standards for transparency, safety, and accountability in IVF and cell management. TMRW's platform, the world's first automated cryo-management for eggs and embryos, provides a complete digital chain of custody fully integrated with a robotic storage and monitoring solution. This is in contrast to the manual and analog methods that have gone unchanged throughout the history of IVF. With TMRW's platform, clinics significantly reduce the chances of potentially devastating errors. The TMRW team includes celebrated innovators in fertility, embryology, cryo-management, automation, software development, and robotics.

TMRW is founded by Joshua Abram, Alan Murray, and Dr. Jeffrey Port in 2018 and is based in New York, New York.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$153.50M
TMRW Life Sciences has raised a total of $153.50M in funding over 2 rounds. Their latest funding was raised on Dec 1, 2022 from a Funding Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 1, 2022 Funding Round 1 Amy Schumer Detail
Jul 21, 2021 Debt Financing Detail
Jul 20, 2021 Series C $105M 10 Transformation Capital Detail
Dec 17, 2019 Series B $36.50M 1 5AM Ventures Detail
May 29, 2019 Series A $12M 1 Special Situations Life Sciences Innovation Fund Detail

Investors

Number of Lead Investors
Number of Investors
4
11
TMRW Life Sciences is funded by 11 investors. Amy Schumer and Transformation Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Amy Schumer Yes Funding Round
Transformation Capital Yes Series C
5AM Ventures Series C
Anne Wojcicki Series C
Casdin Capital Series C
GV Series C
Peter Thiel Series C
Presight Capital Series C
Special Situations Life Sciences Innovation Fund Series C
Susan Wojcicki Series C

Employee Profiles

Number of Employee Profiles
12
TMRW Life Sciences has 12 current employee profiles, including Board member Andrew Schwab
Board member
Board member
Executive
Executive
Board observer